Legend Biotech Corp (LEGN): Insider Trades and Fund Holdings
In the past 12 months, Legend Biotech Corp insiders reported 0 open-market purchases worth $0 and 2 sales worth $309K; 0 of the sales were reported as made under a 10b5-1 trading plan.
Timeline: news and trades
Company filings (8-K), insider trades, notices of planned sales (Form 144) and fund moves in the past year, newest first.
- Sep 29, 2026Insider saleDirector Corazon (corsee) D. Sanders sold $258,920
- Sep 29, 2026Planned saleSanders Corazon (Corsee) D. (director) filed notice to sell about $258,915 around Sep 29, 2026
- Sep 22, 2026Planned saleHuang Ying (former officer & director) filed notice to sell about $1.3 million around Sep 22, 2026
- Sep 22, 2026Planned saleSantos Carlos E (officer) filed notice to sell about $50,854 around Sep 22, 2026
- Sep 21, 2026Insider saleCFO Carlos E. Santos sold $49,630
- Jun 30, 2026FundRenaissance Technologies added 92% in Q2 2026 (13F filed Aug 13, 2026)
Recent insider trades
Open-market purchases (code P) and sales (code S) from Form 4. Grants, option exercises and gifts are not shown. Latest filing: Oct 1, 2026.
| Filed | Insider | Type | Value |
|---|---|---|---|
| Oct 1 | Corazon (corsee) D. SandersDirector | ▼ SELL | $259K |
| Sep 23 | Carlos E. SantosCFO | ▼ SELL | $50K |
Insiders who traded in the past year
| Insider | Role | Buys | Bought | Sells | Sold |
|---|---|---|---|---|---|
| Corazon (corsee) D. Sanders | Director | 0 | $0 | 1 | $259K |
| Carlos E. Santos | CFO | 0 | $0 | 1 | $50K |
Tracked funds that report LEGN
From each fund's latest 13F. Holdings are as of quarter end and are filed up to 45 days later.
| Fund | Shares | Value | Change |
|---|---|---|---|
| Renaissance Technologies | 1,000,200 | $28.9M | ▲ +91.7% |
Reading these numbers
Insiders sell for many reasons: taxes, diversification, a house. Purchases with their own money are rarer and are usually read as more informative. A Form 4 is due within two business days of the trade. How to read a Form 4 →